Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Lida Samie

2PUBLICATIONS

5CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|May 01, 2026

A bioinformatics pipeline for the design of a SART3-targeted cancer vaccine with enhanced immunogenicity.

|Apr 24, 2023

Flavonoids as Strong Inhibitors of MAPK3: A Computational Drug Discovery Approach.

Amir Taherkhani, Parita Khodadadi, Lida Samie

Pageof 1

Frequent Collaborators

2 joint publications

Amir Taherkhani

2 joint publications

Zeynab Bayat

1 joint publications

Parita Khodadadi

1 joint publications

Zahra Azadian

1 joint publications

Faezeh Mahdian-Khoo

Frequent Collaborators

2 joint publications

Amir Taherkhani

2 joint publications

Zeynab Bayat

1 joint publications

Parita Khodadadi

1 joint publications

Zahra Azadian

Top Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Published on : May 10, 2024

See more related videos

Top Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Published on : May 10, 2024

See more related videos